| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |